We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Mativ Holdings
MATV
$481M
| $2.58M | 0.01% |
62,412
-2,409
| -4% | -$104K |
|
|
XXIA
1402
DELISTED
Ixia
XXIA
| $2.57M | 0.01% |
130,690
+35,996
| +38% | +$675K |
|
1403
Ironwood Pharmaceuticals
IRWD
$696M
| $2.57M | 0.01% |
179,650
+7,923
| +5% | +$108K |
|
1404
Standex International
SXI
$3.59B
| $2.57M | 0.01% |
25,631
+7,269
| +40% | +$681K |
|
1405
Merit Medical Systems
MMSI
$5.08B
| $2.56M | 0.01% |
88,683
+28,390
| +47% | +$795K |
|
|
EGOV
1406
DELISTED
NIC Inc
EGOV
| $2.56M | 0.01% |
126,834
-34,943
| -22% | -$784K |
|
|
HAWK
1407
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $2.56M | 0.01% |
62,957
+581
| +0.9% | +$21.5K |
|
1408
Yelp
YELP
$1.45B
| $2.55M | 0.01% |
77,855
+4,137
| +6% | +$153K |
|
|
BOBE
1409
DELISTED
Bob Evans Farms, Inc.
BOBE
| $2.55M | 0.01% |
39,298
+11,266
| +40% | +$636K |
|
1410
Standard Motor Products
SMP
$851M
| $2.55M | 0.01% |
51,801
+6,614
| +15% | +$328K |
|
|
IPHI
1411
DELISTED
INPHI CORPORATION
IPHI
| $2.55M | 0.01% |
52,153
+1,325
| +3% | +$61.9K |
|
1412
Varex Imaging
VREX
$472M
| $2.54M | 0.01% |
+75,606
| New | +$2.39M |
|
|
CSGS
1413
DELISTED
CSG Systems International
CSGS
| $2.54M | 0.01% |
67,087
+19,177
| +40% | +$813K |
|
1414
Hecla Mining
HL
$9.47B
| $2.54M | 0.01% |
479,467
+15,752
| +3% | +$91K |
|
1415
Myriad Genetics
MYGN
$270M
| $2.53M | 0.01% |
131,758
+55,301
| +72% | +$980K |
|
1416
BOK Financial
BOKF
$8.58B
| $2.53M | 0.01% |
32,299
+1,292
| +4% | +$105K |
|
1417
Veeco
VECO
$3.05B
| $2.53M | 0.01% |
84,691
+22,533
| +36% | +$628K |
|
1418
Westlake Corp
WLK
$9.03B
| $2.52M | 0.01% |
38,164
-62,691
| -62% | -$3.97M |
|
|
AGR
1419
DELISTED
Avangrid, Inc.
AGR
| $2.52M | 0.01% |
58,965
+1,994
| +4% | +$81.5K |
|
|
NAVG
1420
DELISTED
Navigators Group Inc
NAVG
| $2.52M | 0.01% |
46,311
+13,079
| +39% | +$730K |
|
1421
Morningstar
MORN
$7.22B
| $2.51M | 0.01% |
31,941
+8,111
| +34% | +$631K |
|
|
AMWD
1422
DELISTED
American Woodmark
AMWD
| $2.51M | 0.01% |
27,299
+7,906
| +41% | +$633K |
|
1423
Capitol Federal Financial
CFFN
$1.09B
| $2.49M | 0.01% |
170,299
+3,749
| +2% | +$57.5K |
|
|
XHR
1424
Xenia Hotels & Resorts
XHR
$1.9B
| $2.49M | 0.01% |
145,675
+9,775
| +7% | +$175K |
|
1425
Inogen
INGN
$175M
| $2.48M | 0.01% |
31,948
+9,659
| +43% | +$669K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.